STAT+: Pharmalittle: Remdesivir props up Gilead’s declining fortunes; U.K. fines drug maker for price hikes
Sales of Gilead Sciences' remdesivir beat analysts' expectations in the second quarter, totaling $829 million.
News
STAT+: Pharmalittle: U.S. lawmaker proposes bill to curtail FDA’s accelerated approval; Moderna to enforce Covid patents in wealthy countries
A powerful Democratic lawmaker introduced a bill that would dramatically rein in the U.S. Food and Drug Administration’s accelerated approval program. […]
News
STAT+: Pharmalittle: Covid-19 pills may take longer to reach poor countries; J&J Covid booster may be as beneficial as a third Pfizer shot
People who received the Pfizer-BioNTech Covid vaccines may get as much benefit from a J&J booster shot as a Pfizer one. […]
News
STAT+: Pharmalittle: Gilead faces partial clinical hold on blood cancer drug; Rhode Island agrees to opioid deal with wholesalers
Rhode Island reversed course and will now support a $21 billion nationwide settlement resolving lawsuits alleging that three large wholesalers fueled the deadly U.S. opioid crisis. […]
